PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC10043419::ACT000068

MPI-N

Evidence text

Paper-level observation

After incubation ... the calculated hemolysis ratio of OMV groups was lower than 5% (Figures 5A, B).
figureConfidence: medium

Assay observation

Activity
Toxicity
Subtype
Hemolytic
Measure
hemolysis
Comparator
<
Raw observation
<5%
Normalized measurement
?–5%
Value minimum
Not reported by source
Value maximum
5%
Target
Mus musculus
Assay method
Not reported by source
Sequence
Not reported by source
Standardization
insufficient information

Source publication

Bioengineered bacterial outer membrane vesicles encapsulated Polybia–mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy

Frontiers in Immunology · 2023

DOI 10.3389/fimmu.2023.1129771 PMC10043419
Parent mention

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.